Page 154 - Imaging News Today

(1) - Clinical utility of Axumin (fluciclovine F 18) being investigated in expanded areas of cancer imaging - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today announced that the first patient has been dosed in its Phase 3 REVELATE clinical trial of 18F-fluciclovine, a positron emission tomography (PET) imaging radiopharmaceutical being studied for potential use in detecting recurrent brain meta...

Schlieren techniques demonstrate patterns of exhaled air spread from wind instruments and singers The airborne spread of pathogens has assumed great importance in the public eye following the onset of the coronavirus disease 2019 (COVID-19 pandemic). In an interesting new research paper published recently on the bioRxiv* preprint server, scientists describe the dispersal of exhaled air, potentially infected, from singers and those playing wind instruments, using Schlieren techniques, a visual ...

Parexel is shedding its medical imaging and informatics biz as the reborn Calyx goes it alone (although still under the Pamplona Capital umbrella).

More than three quarters of COVID-19 patients have at least one ongoing symptom six months after initially becoming unwell, according to research published in The Lancet.

Mass spectrometry imaging shows promise in diagnosing brain diseases Medical professionals all want to be able to quickly and correctly diagnose diseases. Their future ability to do so will depend on identifying what biochemicals are present in tissue sections, where the biomolecules are, and at what concentrations. For this purpose, mass spectrometry imaging—which can identify multiple biochemicals in a single experiment—will be useful. However, the stability of biomolecular sampling needs...

Researchers at Case Western Reserve University and partners in the United States and India are applying the investigative and predictive capabilities of artificial intelligence (AI) to help physicians customize treatments for patients with oral squamous cell carcinomas.

Message : Required fields HOUSTON, Texas, Jan. 05, 2021 (GLOBE NEWSWIRE) -- C4 Imaging LLC is pleased to announce that Isoray Medical, Inc. (NYSE American: ISR) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the use of C4 Imaging’s Sirius® positive-signal MRI (Magnetic Resonance Imaging) Markers with Isoray’s Cesium-131, brachytherapy seeds. Sirius is implanted during the treatment of prostate cancer with brachytherapy and is used to facilitate brachytherapy s...

Novel endoscopic technique improves detection of upper GI tract tumors Recently there have been significant advances on several fronts in the ongoing war against cancer of the alimentary tract. Now, Japanese researchers report the development of another weapon: Linked Color Imaging (LCI), a novel endoscopic technique that improves detection of cancer by viewing the upper digestive tract mucosa under illumination that combines specific wavelengths of light to intensify subtle color variations in...

Anesthesia and sleep have surprisingly similar effects on brain activity, finds study What happens in the brain when our conscious awareness fades during general anesthesia and normal sleep? Finnish scientists studied this question with novel experimental designs and functional brain imaging. They succeeded in separating the specific changes related to consciousness from the more widespread overall effects, and discovered that the effects of anesthesia and sleep on brain activity were surprisin...

$12.99 all you can eat ♪ now with boneless wings. only at applebees. i remember thinking about things i did and wondering if that was the last time i was going to do that thing. i thought...im not letting anything take me away from my family, that loves me and needs me, without a fight. when i came to cancer treatment centers of america, it felt... so different from any other hospital that wed ever been to. whether it be spiritual, so w>>im searching for info being a cancer patient. on options...